Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Drijfhout

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Journal of Immunological Methods|November 30, 1989
Immunological properties of multiple repeats of a linear epitope of herpes simplex virus type 1 glycoprotein DJ R Van der Ploeg, J W Drijfhout, M Feijlbrief, et al.
Archives of Virology|January 1, 1993
T cell responses to synthetic peptides of herpes simplex virus type 1 glycoprotein D in naturally infected individualsR A Damhof, J W Drijfhout, A J Scheffer, et al.
Human Immunology|April 11, 2001
Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpartN C Schloot, S J Willemen, G Duinkerken, et al.
Diabetes|September 30, 1998
HLA-DR binding analysis of peptides from islet antigens in IDDMA Geluk, K E van Meijgaarden, N C Schloot, et al.
Journal of Chromatography|July 20, 1990
Synthetic antibody fragment as ligand in immunoaffinity chromatographyG W Welling, T Geurts, J van Gorkum, et al.
International Journal of Cancer|February 15, 2001
Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic miceL C Heukamp, S H van der Burg, J W Drijfhout, et al.
International Immunology|October 24, 1998
Strongly increased efficiency of altered peptide ligands by mannosylationM C Agnes, A Tan, R Jordens, et al.
Archives of Virology|January 1, 1990
Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein DH J Geerligs, M Feijlbrief, M Bolk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Specific inhibition of the classical complement pathway by C1q-binding peptidesA Roos, A J Nauta, D Broers, et al.
Archives of Virology|January 1, 1994
Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodiesS Welling-Wester, M Feijlbrief, D G Koedijk, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Journal of Immunological Methods|November 30, 1989
Immunological properties of multiple repeats of a linear epitope of herpes simplex virus type 1 glycoprotein DJ R Van der Ploeg, J W Drijfhout, M Feijlbrief, et al.
Archives of Virology|January 1, 1993
T cell responses to synthetic peptides of herpes simplex virus type 1 glycoprotein D in naturally infected individualsR A Damhof, J W Drijfhout, A J Scheffer, et al.
Human Immunology|April 11, 2001
Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpartN C Schloot, S J Willemen, G Duinkerken, et al.
Diabetes|September 30, 1998
HLA-DR binding analysis of peptides from islet antigens in IDDMA Geluk, K E van Meijgaarden, N C Schloot, et al.
Journal of Chromatography|July 20, 1990
Synthetic antibody fragment as ligand in immunoaffinity chromatographyG W Welling, T Geurts, J van Gorkum, et al.
International Journal of Cancer|February 15, 2001
Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic miceL C Heukamp, S H van der Burg, J W Drijfhout, et al.
International Immunology|October 24, 1998
Strongly increased efficiency of altered peptide ligands by mannosylationM C Agnes, A Tan, R Jordens, et al.
Archives of Virology|January 1, 1990
Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein DH J Geerligs, M Feijlbrief, M Bolk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Specific inhibition of the classical complement pathway by C1q-binding peptidesA Roos, A J Nauta, D Broers, et al.
Archives of Virology|January 1, 1994
Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodiesS Welling-Wester, M Feijlbrief, D G Koedijk, et al.
Pageof 10